Agendia BV’s MammaPrint(R) Micro-Array Test Confirmed To Be A Reliable Diagnostic Tool For Breast Cancer

AMSTERDAM, THE NETHERLANDS -- (MARKET WIRE) -- November 08, 2006 -- In a publication entitled ‘Converting a breast cancer microarray signature into a high-throughput diagnostic test’ in the international journal BMC Genomics, made available online on October 31 2006, it is shown that micro-array technology can be a reliable tool for use in a clinical diagnostic setting.

MORE ON THIS TOPIC